Wednesday, July 19, 2017 11:36 PM EST
BxWorld Fund entered a position in Soligenix (ticker SNGX), a biotech company with some interesting products for the cure of cancer and a range of products against bioterrorism and radioactive warfare.
In this article: SNGX
Latest Comments
Why Be A Contributor To TalkMarkets
GOOD idea talkmarkets